Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.
"Walletinvester.com predicts an sp of 2.735p in 2020"
That would be great.
The US and China in talks again relative to the present Trade war between
the Us and China which is not doing the US any good.
And last time the discussions looked like maybe a compromise on the trade war
Provexis share price shot up to 1.2p. and then fell again as no deal was the outcome.
Trade war is not good for the market economy in general but as the Chinese company
By-Health is now researching the benefits of Fruitflow to produce and sell in China and around
the world and ensuring patents around the world are in place then a positive result from the
latest trade war discussions will positively effect our share price. IMHO
I like this one best:-
https://www.instagram.com/fruitflowplus/
If this September the trade war between the US and China is sorted out and
If Provexis results show an increase in revenue again;
And if half the revenue increase has not been spent on more and more patents around the world getting ready for Fruitflow to be sold around the world.
And if the Chinese company By-Health who have just confirmed a collaboration deal to produce Fruitflow as soon as the Chinese authorities confirm the health benefits start producing and selling Fruitflow products in China,
Then no reason why Provexis share price should not rise to reflect these facts.
If this September the trade war between the US and China is sorted out and
If Provexis results show an increase in revenue;
And if half the revenue increase has not been spent on more and more patents around the world.
And if the Chinese company By-Health start producing and selling Fruitflow products in China,
Then no reason why our share price should not rise to reflect these facts.
China is a massive market for the heart health product Fruitflow and only today on the internet the
scientists latest research has recognised that we all have what they now call ugly cholesterol which is the
main cause of heart attacks and strokes and high blood pressure.
And Fruitflow, on sale in Holland and Barrett and now soon to on sale in China maintains a healthy blood flow, and
we all need to check out this factor.
Checkout other websites and most ssy PXS share price 3.3p/3.2p
and on Nex exchange you see some more big buys today.
Key Information
ISIN: GB00B0923P27
Symbol: PXS.GB
MiFID Status: Regulated Market
Please see primary market for more information
Latest Trades
Date & Time Volume Price
12/08/2019 15:19 3,000,000 0.35
12/08/2019 14:06 8,046 0.285
12/08/2019 10:11 5,000,000 0.33
05/08/2019 15:45 15,998 0.305
05/08/2019 08:10 18,361 0.354View latest trades
6th August 2019 launch in China of Fruitflow drink:-
http://www.cjhouse.com.cn/a/jiankang/2019/0806/39232.html
I like this one best, looks like a great refreshing healthy drink including our Fruitflow
and a healthy fit Chinese girl drinking it.
http://www.cjhouse.com.cn/a/jiankang/2019/0806/39232.html
"Weixin's new product “?” draws on the flavor of light lactic acid bacteria popular in the West and Dongpu in recent years—except for the quenching thirst function of conventional water, and the addition of different types of special lactic acid bacteria can help the stomach. In addition, while maintaining the light lactic acid bacteria, "?" has added two factors, fruitflow and Y-aminobutyric acid, which can promote blood flow health and relieve tension and stress. It is reported that this "flavor power ?" has the quality and color of French Evian water and the flavor and taste of lycopium Calpis lactic acid water, which makes people feel at ease."
Note: "all projects envisaged to be at By-Health's sole expense."
"The Agreement has been structured on an open-ended framework basis, enabling the parties to conduct a number of different projects over an unspecified period of time under the one overriding agreement, with all projects envisaged to be at By-Health's sole expense."
"It is envisaged that projects conducted under the agreement will be focussed on specific areas of commercial focus for By-Health, and the first project which has been agreed will concentrate on the use of Fruitflow with nitrates in exercise, an area of considerable commercial interest to By-Health in China."
Hence, in my opinion, By-Health in agreement with DSM and Provexis is waiting for plans/projects on Fruitflow and Blue Cap confirmation before they put in an offer to buy us out.IMHO
"It is envisaged that project work will be managed and conducted by Provexis primarily in the UK, led by Provexis' Chief Scientific Officer Dr Niamh O'Kennedy and supported by outsourced research partners which will be appointed and managed by Provexis."
Massive potential if all goes to plan.
Gixer:- You are usually right.
Hence, based on your knowledge we should be getting an update on the Blue Cap submission on Fruitflow by October this year giving By-Health the Green Light to produce and sell new Fruitflow products in China and around the world.
You say "Blue Hat should take around 34 weeks unless a Re-test and on-site verification is requested." based on the fact that:-
"BY-HEALTH intends to make its first blue cap submission to the SAMR for Fruitflow® in February 2019, with a further blue cap submission envisaged later in 2019, both to include references to the Company's existing European Food Safety Authority ('EFSA') health claim for Fruitflow."
Hence, All looking good, By-Health getting ready to produce more Fruitflow products in China for a massive market and interesting that DSM is now upgrading expanding its factory in China to produce more of Vitamin C etc. by the end of the year. which in my opinion will include a new Fruitflow product plus vitamin C, - All our partners are working together and 2019 is going to be the start of a year on year of new Fruitflow products to be produced and sold to the massive market in China. IMHO
Ten years ago, yes ten years ago based on a potential deal with Co-ca-cola the share price shot up to above 15p from 0.5p in less then a year. and we now have a signed up deal with By-Health with a massive potential. - All looking good and at By-healths expense.
"Clinical studies conducted in China are typically required to obtain blue cap health claim status, and a significant investment in seven separate studies, in support of the Fruitflow based products which By-Health plans to launch in China, is being undertaken at By-Health's expense."
From Provexis web site:-
"The planned launch by By-Health of a number of Fruitflow based products in the Chinese market, with potential volumes at a significant multiple of existing Fruitflow sales, is progressing well, with activities driven at present by the need to obtain 'blue cap' health claim status for Fruitflow as a dietary supplement with the Chinese State Administration for Market Regulation (SAMR)."
When you checkout the market responds to Provexis over the years it was all negative but today
it is now a buy.
https://uk.tradingview.com/symbols/LSE-PXS/
Market response:-
https://uk.tradingview.com/symbols/LSE-PXS/
Shanghai, CN, 17 Jul 2019 09:00 CEST
Interesting that DSM our partner and confirmed today our collaboration partner with By-Health to further expand and research and produce and sell Fruitflow in China and as stated below DSM is extending its vitamin C plant in China with the latest upgrades.
In my opinion the partnership between DSM and By-Health and Provexis and all the products they now already produce in China equals a massive potential for more and more Fruitflow products to be produced in China and like today our share price will reflect these factors over the next couple of years. IMHO
From DSMs web site:-
“DSM continues to invest in improving the performance of its vitamin C plant in Jiangshan, China, as part of its ongoing commitment to quality, safety, sustainability and production efficiencies. DSM will extend its annual shutdown to implement additional upgrades in these areas across the site.”
“This shutdown has started earlier this month, with the latest upgrades to be completed by start Q4 2019.”
Update we have all been waiting fore:-
"Provexis, up 17%. The food ingredients retailer signed a collaboration agreement with Chinese dietary supplement firm By-Health Co Ltd for the launch of Fruitflow-based products in China. The agreement has been structured on an open-ended framework basis, which will allow both companies to conduct several different projects over an unspecified period of time, to be at By-Health sole expense. Projects conducted under the agreement will be focused on specific areas of commercial focus for By-Health, with the first project to concentrate on the use of Fruitflow with nitrates in exercise. The nitrates project is expected to provide gross income to Provexis in excess of GBP55,000, and will now affect the company's ownership of existing intellectual property for the nitrates formulation. Project work is to be managed and conducted by Provexis mainly in the UK, and supported by outsourced research partners that will be appointed by the company."
DSM, our partner with By-Health on producing Fruitflow in China half year results and event details to be published on 1st August 2019.
Interesting that our update has been postponed until end of this month or maybe now on the same day as DSM as some shared good regulated news on how our partnership with By-Health has progressed. IMHO
All seems very positive to me.
From DSMs website:-
"Publication - Half year results 2019"
Event details:
Date:
01 Aug 2019
End Date:
01 Aug 2019
Location:
TBC
In attendance:
TBC
Website:
www.dsm.com
Bloomberg news tonight:-
Trade talks between the US and China set to resume on Tuesday in Shanghai and in
my opinion this will have a positive influence on the Market in general, and will have a positive
influence relative to By-Health planning to produce and sell Fruitflow in China and around the world in
partnership with DSM. IMHO.
And as we are all experiencing the knock on health ill effects of the Heat wave, doctors are concerned about
how our sticky blood platelets are sticking more and more together resulting in a rise in blood pressure and heart attacks and strokes.
Fruitflow Massive Potential.